Contraindications
CV disease; moderate to severe hypertension; hyperthyroidism; glaucoma; hyperexcitablity or agitated state; history of drug/alcohol abuse; advanced arteriosclerosis; pregnancy; lactation.
|
Special Precautions
Mild hypertension; impaired kidney function or unstable personality. Monitor child weight and height. Psychoses may be exacerbated. Dependence. Epilepsy. Gradual withdrawal is recommended after prolonged treatment.
|
Adverse Reactions
Insomnia, night terrors, nervousness, restlessness, irritability, euphoria; fatigue, depression; dry mouth, anorexia, abdominal cramps, headache, dizziness, tremor, sweating, tachycardia, palpitations, hypo- or hypertension, impotence and altered libido. Psychosis, muscle damage and renal complications.
|
Overdosage
May cause hallucination, psychosis and death.
|
Drug Interactions
Increased risk of arrhythmias when used with volatile liquid anaesthetics or TCAs.
Potentially Fatal: Concurrent use with MAOIs or within 14 days of discontinuing MAOI treatment may precipitate hypertensive crisis. |
Action
Description:
Mechanism of Action: Prolintane is a mild central stimulant. It acts indirectly as a sympathomimetic. |
MIMS Class
|